Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 266 articles:
HTML format
Text format



Single Articles


    June 2018
  1. RAO M, Onkar S, Peachman KK, White Y, et al
    Liposome-Encapsulated HIV-1 gp120 Induces Potent V1V2-Specific Antibodies in Humans.
    J Infect Dis. 2018 Jun 9. pii: 5035293. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. ALI A, Ng HL, Blankson JN, Burton DR, et al
    Highly Attenuated Infection with a Vpr-Deleted Molecular Clone of HIV-1.
    J Infect Dis. 2018 Jun 7. pii: 5033983. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. LIDOFSKY A, Holmes JA, Feeney ER, Kruger AJ, et al
    Macrophage Activation Marker Soluble CD163 is a Dynamic Marker of Liver Fibrogenesis in HIV/HCV Coinfection.
    J Infect Dis. 2018 Jun 4. pii: 5032604. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. D'ANTONI ML, Byron MM, Chan P, Sailasuta N, et al
    Normalization of Soluble CD163 after Institution of Antiretroviral Therapy During Acute HIV Infection Tracks with Fewer Neurological Abnormalities.
    J Infect Dis. 2018 Jun 2. pii: 5032504. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  5. JOHNSON EL, Boggavarapu S, Johnson ES, Lal A, et al
    HCMV enhances placental susceptibility and replication of HIV-1 which may facilitate in utero HIV-1 transmission.
    J Infect Dis. 2018 May 31. pii: 5026120. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. KELLY H, Faust H, Chikandiwa A, Ngou J, et al
    Human Papillomavirus Serology Among Women Living With HIV: Type-Specific Seroprevalence, Seroconversion, and Risk of Cervical Reinfection.
    J Infect Dis. 2018 May 30. pii: 5025554. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. PERCIANI CT, Sekhon M, Hundal S, Farah B, et al
    Live-attenuated Zoster Vaccine Boosts VZV-specific Humoral Responses Systemically and at the Cervico-vaginal Mucosa of Kenyan VZV-seropositive Women.
    J Infect Dis. 2018 May 25. pii: 5003463. doi: 10.1093.
    PubMed     Text format     Abstract available


  8. ANDERSEN MN, Honge BL, Jespersen S, Medina C, et al
    Soluble Macrophage Mannose Receptor (sCD206/sMR) as a Biomarker in HIV-infection.
    J Infect Dis. 2018 May 25. pii: 5003428. doi: 10.1093.
    PubMed     Text format     Abstract available


  9. VON MOLLENDORF C, Hellferscee O, Valley-Omar Z, Treurnicht FK, et al
    Influenza viral shedding in a prospective cohort of HIV-infected and -uninfected children and adults in 2 provinces of South Africa, 2012-2014.
    J Infect Dis. 2018 May 24. pii: 5002738. doi: 10.1093.
    PubMed     Text format     Abstract available



  10. Erratum to Evaluating the Impact of Functional Genetic Variation on HIV-1 Control.
    J Infect Dis. 2018 May 24. pii: 5003198. doi: 10.1093.
    PubMed     Text format    


  11. DOBARD CW, Makarova N, West-Deadwyler R, Taylor A, et al
    Efficacy of Vaginally Administered Gel Containing Emtricitabine and Tenofovir Against Repeated Rectal SHIV Exposures in Macaques.
    J Infect Dis. 2018 May 21. pii: 4999973. doi: 10.1093.
    PubMed     Text format     Abstract available


  12. LANGKILDE A, Tavenier J, Danielsen AV, Eugen-Olsen J, et al
    Histological and Molecular Adipose Tissue Changes are related to Metabolic Syndrome rather than Lipodystrophy in HIV-infected Patients-A Cross-Sectional Study.
    J Infect Dis. 2018 May 17. pii: 4997383. doi: 10.1093.
    PubMed     Text format     Abstract available


  13. TWISK DE, van der Sande MAB, van Eeden A, Heideman DAM, et al
    Detection of Incident Anal High-Risk Hpv-Dna in Msm: Incidence or Reactivation?
    J Infect Dis. 2018 May 16. pii: 4996623. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. REICHLER MR, Khan A, Sterling TR, Zhao H, et al
    Risk and Timing of Tuberculosis Among Close Contacts of Persons with Infectious Tuberculosis.
    J Infect Dis. 2018 May 15. pii: 4996045. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. KOAY WLA, Lindsey JC, Uprety P, Bwakura-Dangarembizi M, et al
    Intestinal Integrity Biomarkers in Early Antiretroviral-Treated Perinatally HIV-1-Infected Infants.
    J Infect Dis. 2018 May 12. pii: 4995578. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. NALWOGA A, Cose S, Nash S, Miley W, et al
    Relationship between Anaemia, Malaria Co-infection and Kaposi Sarcoma-associated Herpesvirus (KSHV) Seropositivity in a Population-based Study in Rural Uganda.
    J Infect Dis. 2018 May 8. pii: 4993751. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. CHAN P, Patel P, Hellmuth J, Colby DJ, et al
    Distribution of HIV RNA in CSF and Blood is linked to CD4/CD8 Ratio During Acute HIV.
    J Infect Dis. 2018 May 7. pii: 4993332. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. FARMAKI PF, Chini MC, Mangafas NM, Tzanoudaki MT, et al
    Immunogenicity and Immunological Memory Induced by the 13-Valent Pneumococcal Conjugate Followed by the 23-Valent Polysaccharide Vaccine in HIV-Infected Adults.
    J Infect Dis. 2018 May 2. pii: 4990938. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  19. SIEDNER MJ, Zanni M, Tracy RP, Kwon DS, et al
    Increased Systemic Inflammation and Gut Permeability Among Women with Treated HIV Infection in Rural Uganda.
    J Infect Dis. 2018 Apr 28. pii: 4989852. doi: 10.1093.
    PubMed     Text format     Abstract available


  20. KOSTAKI EG, Nikolopoulos GK, Pavlitina E, Williams L, et al
    Molecular analysis of HIV-1 infected individuals in a network-based intervention (TRIP): Phylogenetics identify HIV-1 infected individuals with social links.
    J Infect Dis. 2018 Apr 24. pii: 4984584. doi: 10.1093.
    PubMed     Text format     Abstract available


  21. COLBY DJ, Posuwan N, Kroon E, Phanuphak N, et al
    Reply to Chen et al.
    J Infect Dis. 2018 Apr 23. pii: 4982816. doi: 10.1093.
    PubMed     Text format    


  22. HOSHINO A, Takashima T, Yoshida K, Morimoto A, et al
    Dysregulation of Epstein-Barr virus infection in hypomorphic ZAP70 mutation.
    J Infect Dis. 2018 Apr 19. pii: 4976509. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. LIN KY, Hsieh SM, Sheng WH, Lo YC, et al
    Comparable serologic responses to 2 different combinations of inactivated HAV vaccines in HIV-positive patients during the acute hepatitis A outbreak in Taiwan.
    J Infect Dis. 2018 Apr 16. pii: 4972613. doi: 10.1093.
    PubMed     Text format     Abstract available


  24. BADEN LR, Walsh SR, Seaman MS, Cohen YZ, et al
    First-in-Human Randomized Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.
    J Infect Dis. 2018 Apr 13. pii: 4969772. doi: 10.1093.
    PubMed     Text format     Abstract available


  25. REICHLER MR, Bangura J, Bruden D, Keimbe C, et al
    Household Transmission of Ebola Virus: risks and preventive factors, Freetown, Sierra Leone, 2015.
    J Infect Dis. 2018 Apr 6. pii: 4962469. doi: 10.1093.
    PubMed     Text format     Abstract available


  26. BRADLEY J, Floyd S, Piwowar-Manning E, Laeyendecker O, et al
    Sexually Transmitted Bedfellows: Exquisite Association between HIV and HSV2 in 21 Communities in Southern Africa in the HPTN 071 (PopART) Study.
    J Infect Dis. 2018 Apr 6. pii: 4962568. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  27. PRINCIOTTO AM, Vrbanac VD, Melillo B, Park J, et al
    A Small-Molecule CD4-mimetic Compound Protects BLT Humanized Mice from Human Immunodeficiency Virus Infection.
    J Infect Dis. 2018 Mar 29. pii: 4956165. doi: 10.1093.
    PubMed     Text format     Abstract available


  28. PHAM HT, Labrie L, Wijting IEA, Hassounah S, et al
    The S230R Integrase Substitution Associated with Viral Rebound during DTG Monotherapy Confers Low Levels INSTI Drug Resistance.
    J Infect Dis. 2018 Mar 29. pii: 4956223. doi: 10.1093.
    PubMed     Text format     Abstract available


  29. WIJTING IEA, Lungu C, Rijnders BJA, van der Ende ME, et al
    HIV-1 resistance dynamics in patients failing dolutegravir maintenance monotherapy.
    J Infect Dis. 2018 Mar 29. pii: 4956224. doi: 10.1093.
    PubMed     Text format     Abstract available


  30. SCHUSTER C, Mayer FJ, Wohlfahrt C, Marculescu R, et al
    Acute HIV Infection Results in Subclinical Inflammatory Cardiomyopathy.
    J Infect Dis. 2018 Mar 28. pii: 4955987. doi: 10.1093.
    PubMed     Text format     Abstract available


  31. SSEMWANGA D, Doria-Rose NA, Redd AD, Shiakolas AR, et al
    Characterization of the Neutralizing Antibody Response in a Case of Genetically Linked HIV Superinfection.
    J Infect Dis. 2018 Mar 22. pii: 4932787. doi: 10.1093.
    PubMed     Text format     Abstract available


  32. POON AFY, Dearlove BL
    Quantifying the aftermath: Recent Outbreaks among People who in- ject Drugs and the Utility of Phylodynamics.
    J Infect Dis. 2018 Mar 13. pii: 4931170. doi: 10.1093.
    PubMed     Text format    


  33. MURRAY LW, Satti I, Meyerowitz J, Jones M, et al
    Human Immunodeficiency Virus Infection Impairs Th1 and Th17 Mycobacterium tuberculosis-Specific T-Cell Responses.
    J Infect Dis. 2018 Mar 13. pii: 4932783. doi: 10.1093.
    PubMed     Text format     Abstract available


  34. RAGONNET-CRONIN M, Jackson C, Bradley-Stewart A, Aitken C, et al
    Recent and Rapid Transmission of HIV among People who Inject Drugs in Scotland Revealed through Phylogenetic Analysis.
    J Infect Dis. 2018 Mar 13. pii: 4931169. doi: 10.1093.
    PubMed     Text format     Abstract available


  35. STROUVELLE VP, Braun DL, Vongrad V, Scherrer AU, et al
    No Effect of Pegylated Interferon-alpha on Total Hiv-1 DNA Load in HIV-1/HCV Coinfected Patients.
    J Infect Dis. 2018 Mar 8. pii: 4924783. doi: 10.1093.
    PubMed     Text format     Abstract available


  36. THOMSON KA, Hughes J, Baeten JM, John-Stewart G, et al
    Increased Risk of Female HIV-1 Acquisition Throughout Pregnancy and Postpartum: A Prospective Per-coital Act Analysis Among Women with HIV-1 Infected Partners.
    J Infect Dis. 2018 Mar 5. pii: 4915924. doi: 10.1093.
    PubMed     Text format     Abstract available


  37. STEFIC K, Novelli S, Mahjoub N, Seng R, et al
    Non-reactive HIV-1 Rapid Tests after Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection.
    J Infect Dis. 2018 Mar 2. pii: 4917573. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  38. MOFENSON LM
    Risk of HIV Acquisition during Pregnancy and Postpartum: A Call for Action.
    J Infect Dis. 2018 Feb 28. pii: 4913312. doi: 10.1093.
    PubMed     Text format    


  39. VOLZ EM, Le Vu S, Ratmann O, Tostevin A, et al
    Molecular Epidemiology of HIV-1 Subtype B Reveals Heterogeneous Transmission Risk: Implications for Intervention and Control.
    J Infect Dis. 2018 Feb 26. pii: 4915980. doi: 10.1093.
    PubMed     Text format     Abstract available


  40. BAETEN JM
    Amplifying the Population Health Benefits of PrEP for HIV Prevention.
    J Infect Dis. 2018 Feb 26. pii: 4915988. doi: 10.1093.
    PubMed     Text format    


  41. MARGOLICK JB, Bream JH, Nilles TL, Li H, et al
    Relationship Between T-Cell Responses to CMV, Markers of Inflammation, and Frailty in HIV-uninfected and HIV-infected Men in the Multicenter AIDS Cohort Study.
    J Infect Dis. 2018 Feb 26. pii: 4909741. doi: 10.1093.
    PubMed     Text format     Abstract available


  42. GANDHI M, Gandhi RT, Stefanescu A, Bosch RJ, et al
    Cumulative Antiretroviral Exposure Measured in Hair Is Not Associated With Measures of HIV Persistence or Inflammation Among Individuals on Suppressive ART.
    J Infect Dis. 2018 Feb 26. pii: 4848924. doi: 10.1093.
    PubMed     Text format     Abstract available


  43. RODRIGUEZ KM, Khalili J, Trevillian J, Currier J, et al
    What is the best model for HIV Primary Care? Assessing the influence of provider type on outcomes of chronic co-morbidities in HIV.
    J Infect Dis. 2018 Feb 22. pii: 4898101. doi: 10.1093.
    PubMed     Text format    


  44. KOJIC EM, Conley L, Bush T, Cu-Uvin S, et al
    Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types covered by Current HPV Vaccines among HIV-Infected Women in the Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (The SUN Study
    J Infect Dis. 2018 Feb 14. pii: 4857222. doi: 10.1093.
    PubMed     Text format     Abstract available


  45. KURODA MJ, Sugimoto C, Cai Y, Merino KM, et al
    High Turnover of Tissue Macrophages Contributes to Tuberculosis Reactivation in Simian Immunodeficiency Virus-Infected Rhesus Macaques.
    J Infect Dis. 2018 Feb 8. pii: 4843840. doi: 10.1093.
    PubMed     Text format     Abstract available


  46. KHAN N, Divangahi M
    Mycobacterium tuberculosis and HIV Coinfection Brings Fire and Fury to Macrophages.
    J Infect Dis. 2018 Feb 8. pii: 4843841. doi: 10.1093.
    PubMed     Text format    


  47. UTAY NS, Kitch DW, Yeh E, Fichtenbaum CJ, et al
    Telmisartan Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued ART Alone.
    J Infect Dis. 2018 Feb 1. pii: 4833221. doi: 10.1093.
    PubMed     Text format     Abstract available


  48. SHANG L, Smith AJ, Duan L, Perkey KE, et al
    Vaccine-associated maintenance of epithelial integrity correlated with protection against virus entry.
    J Infect Dis. 2018 Feb 1. pii: 4833184. doi: 10.1093.
    PubMed     Text format     Abstract available


  49. BURBELO PD, Price RW, Hagberg L, Hatano H, et al
    Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
    J Infect Dis. 2018 Feb 1. pii: 4834093. doi: 10.1093.
    PubMed     Text format     Abstract available


  50. CLIFFORD DB
    Could We Harness Human Immunodeficiency Virus Antibodies to Monitor the Brain?
    J Infect Dis. 2018 Feb 1. pii: 4832662. doi: 10.1093.
    PubMed     Text format    


    January 2018
  51. COMBES JD, Heard I, Poizot-Martin I, Canestri A, et al
    Prevalence and risk factors for anal human papillomavirus infection in HIV-positive men having sex with men.
    J Infect Dis. 2018 Jan 31. pii: 4830905. doi: 10.1093.
    PubMed     Text format     Abstract available


  52. ALLERS K, Kunkel D, Hofmann J, Stahl-Hennig C, et al
    Cell-associated SIV Accelerates Initial Virus Spread and CD4+ T cell Depletion in the Intestinal Mucosa.
    J Infect Dis. 2018 Jan 30. pii: 4829896. doi: 10.1093.
    PubMed     Text format     Abstract available


  53. WILSON P, Parr JB, Jhaveri R, Meshnick SR, et al
    Call to action: Prevention of mother-to-child transmission of hepatitis B in Africa.
    J Infect Dis. 2018 Jan 17. pii: 4812591. doi: 10.1093.
    PubMed     Text format     Abstract available


  54. COLLADO-DIAZ V, Andujar I, Sanchez-Lopez A, Orden S, et al
    Abacavir induces arterial thrombosis in a murine model.
    J Infect Dis. 2018 Jan 16. pii: 4810700. doi: 10.1093.
    PubMed     Text format     Abstract available


  55. PANDEY JP
    HIV-1 Control and Immunoglobulin Genes.
    J Infect Dis. 2018 Jan 15. pii: 4808592. doi: 10.1093.
    PubMed     Text format    


  56. FONG Y, Shen X, Ashley VC, Deal A, et al
    Vaccine-induced antibody responses modify the association between T-cell immune responses and HIV-1 infection risk in HVTN 505.
    J Infect Dis. 2018 Jan 8. pii: 4792964. doi: 10.1093.
    PubMed     Text format     Abstract available


  57. REID M, Ma Y, Scherzer R, Price JC, et al
    Contribution of liver fibrosis and microbial translocation to immune activation in HIV and HCV.
    J Infect Dis. 2018 Jan 3. pii: 4786614. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2017
  58. ANGELIDOU K, Hunt PW, Landay AL, Wilson CC, et al
    Changes in inflammation but not in T cell activation precede non-AIDS-defining events in a case-control study of patients on long-term antiretroviral therapy.
    J Infect Dis. 2017 Dec 22. pii: 4772233. doi: 10.1093.
    PubMed     Text format     Abstract available


  59. KOOIJ KW, Vogt L, Reiss P
    Reply to Moso et al.
    J Infect Dis. 2017 Dec 22. pii: 4772651. doi: 10.1093.
    PubMed     Text format    


  60. MOSO MA, Woolnough E, Langham F, Hoy JF, et al
    Increasing prevalence and risk of chronic kidney disease in HIV-positive individuals: changing demographics over a six-year period.
    J Infect Dis. 2017 Dec 22. pii: 4772637. doi: 10.1093.
    PubMed     Text format    


  61. TANSEY C, Zhao C, Hopkins A, Ritter JM, et al
    A Non-human Primate Model for Rectally Transmitted Syphilis.
    J Infect Dis. 2017 Dec 22. pii: 4772175. doi: 10.1093.
    PubMed     Text format     Abstract available


  62. GIBBS A, Buggert M, Edfeldt G, Ranefall P, et al
    HIV-infected women have high numbers of CD103-CD8+ T cells residing close to the basal membrane of the ectocervical epithelium.
    J Infect Dis. 2017 Dec 20. pii: 4767924. doi: 10.1093.
    PubMed     Text format     Abstract available


  63. SHIELS MS, Kirk GD, Drummond MB, Dhillon D, et al
    HIV Infection and Circulating Levels of Prosurfactant Protein B and Surfactant Protein D.
    J Infect Dis. 2017 Dec 19. pii: 4762465. doi: 10.1093.
    PubMed     Text format     Abstract available


  64. WALLENDER E, Vucicevic K, Jagannathan P, Huang L, et al
    Predicting optimal dihydroartemisinin-piperaquine regimens to prevent malaria during pregnancy for HIV-infected women receiving efavirenz.
    J Infect Dis. 2017 Dec 19. pii: 4762345. doi: 10.1093.
    PubMed     Text format     Abstract available


  65. GALLANT J, Hsue PY, Shreay S, Meyer N, et al
    Comorbidities Among US Patients With Prevalent HIV Infection-A Trend Analysis.
    J Infect Dis. 2017;216:1525-1533.
    PubMed     Text format     Abstract available


  66. VAN DER VALK M, Reiss P
    Noncommunicable Diseases in People Living With HIV: Time for Integrated Care.
    J Infect Dis. 2017;216:1481-1483.
    PubMed     Text format    


  67. BOPPANA SB, Britt WJ, Fowler K, Hutto SC, et al
    Pathogenesis of Non-Zika Congenital Viral Infections.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  68. GREGORY CJ, Oduyebo T, Brault AC, Brooks JT, et al
    Modes of Transmission of Zika Virus.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  69. SIEDNER MJ, Hunt PW
    All About the Albumin? Prognostic Capacity of Serum Albumin in Patients With Treated HIV Infection.
    J Infect Dis. 2017 Dec 13. pii: 4736315. doi: 10.1093.
    PubMed     Text format    


  70. RONIT A, Sharma S, Baker JV, Mngqibisa R, et al
    Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study.
    J Infect Dis. 2017 Dec 13. pii: 4736314. doi: 10.1093.
    PubMed     Text format     Abstract available


  71. KING CC, Ellington SR, Davis NL, Coombs RW, et al
    Prevalence, Magnitude, and Correlates of HIV-1 Genital Shedding in Women on Antiretroviral Therapy.
    J Infect Dis. 2017 Dec 12. pii: 4733301. doi: 10.1093.
    PubMed     Text format     Abstract available


  72. HAYASHI K, Dong H, Kerr T, Dobrer S, et al
    Declining Mortality Rates in HIV-Infected People Who Inject Drugs During a Seek-and-Treat Initiative in Vancouver, Canada, 1996-2014: A Prospective Cohort Study.
    J Infect Dis. 2017 Dec 12. pii: 4731720. doi: 10.1093.
    PubMed     Text format     Abstract available


  73. SIVRO A, McKinnon LR
    Mucosal HIV Shedding During ART.
    J Infect Dis. 2017 Dec 12. pii: 4733302. doi: 10.1093.
    PubMed     Text format    


  74. RANGANATH N, Sandstrom TS, Burke Schinkel SC, Cote SC, et al
    The oncolytic virus, MG1, targets and eliminates latently HIV-1-infected cells: implications for an HIV cure.
    J Infect Dis. 2017 Dec 8. pii: 4706282. doi: 10.1093.
    PubMed     Text format     Abstract available


  75. AJAYKUMAR A, Soudeyns H, Kakkar F, Brophy J, et al
    Leukocyte telomere length at birth and during the early life of HIV-exposed uninfected children following in utero exposure to antiretrovirals.
    J Infect Dis. 2017 Dec 8. pii: 4706016. doi: 10.1093.
    PubMed     Text format     Abstract available


  76. NYITRAY AG, Fujimoto K, Zhao J, Giuliano AR, et al
    Prevalence of and risk factors for anal HPV among a sample of predominantly black men who have sex with men in Houston, Texas.
    J Infect Dis. 2017 Dec 5. pii: 4690591. doi: 10.1093.
    PubMed     Text format     Abstract available


  77. PATEL P, Bush T, Kojic EM, Conley L, et al
    Prevalence, incidence, and clearance of anal high-risk human papillomavirus (HPV) infection among HIV-infected men in the SUN Study.
    J Infect Dis. 2017 Dec 4. pii: 4689803. doi: 10.1093.
    PubMed     Text format     Abstract available


  78. STELLA-ASCARIZ N, Arribas JR, Paredes R, Li JZ, et al
    The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  79. WALLIS CL, Godfrey C, Fitzgibbon JE, Mellors JW, et al
    Key Factors Influencing the Emergence of Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Countries.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  80. RAIZES E, Hader S, Birx D
    Expansion of Viral Load Testing and the Potential Impact on HIV Drug Resistance.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


    November 2017
  81. MAKVANDI-NEJAD S, Laurenson-Schafer H, Wang L, Wellington D, et al
    Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection.
    J Infect Dis. 2017 Nov 30. pii: 4676001. doi: 10.1093.
    PubMed     Text format     Abstract available


  82. ANDREI G, Gillemot S, Topalis D, Snoeck R, et al
    The anti-HIV drug tenofovir, a reverse transcriptase inhibitor, also targets the herpes simplex virus (HSV) DNA polymerase.
    J Infect Dis. 2017 Nov 23. pii: 4653578. doi: 10.1093.
    PubMed     Text format     Abstract available


  83. BOON D, Redd AD, Layendecker O, Engle R, et al
    Hepatitis E virus seroprevalence and correlates of anti-HEV IgG antibodies in the Rakai District, Uganda.
    J Infect Dis. 2017 Nov 23. pii: 4653785. doi: 10.1093.
    PubMed     Text format     Abstract available


  84. JUSTICE AC, Erlandson KM, Miotti PG, Landay A, et al
    Can Biomarkers Advance HIV Research and Care in the ART Era?
    J Infect Dis. 2017 Nov 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  85. CHAUDHURY CS, Sheehan J, Chairez C, Akoth E, et al
    No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV.
    J Infect Dis. 2017 Nov 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  86. BUTI M, Riveiro-Barciela M, Esteban R
    Tenofovir Alafenamide Fumarate: A New Tenofovir Prodrug for the Treatment of Chronic Hepatitis B Infection.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  87. YEN YF, Lan YC, Huang CT, Jen IA, et al
    Human Immunodeficiency Virus Infection Increases the Risk of Incident Autoimmune Hemolytic Anemia: A Population-Based Cohort Study in Taiwan.
    J Infect Dis. 2017;216:1000-1007.
    PubMed     Text format     Abstract available


  88. HUANG YA, Tao G, Samandari T, Hoover KW, et al
    Laboratory Testing of a Cohort of Commercially Insured Users of HIV Preexposure Prophylaxis in the United States, 2011-2015.
    J Infect Dis. 2017 Nov 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  89. STEBA GS, Koekkoek SM, Vanhommerig JW, Brinkman K, et al
    DC-SIGN Polymorphisms Associated with Risk of Hepatitis C Virus Infection Among Men who Have Sex with Men but not Among Injecting Drug Users.
    J Infect Dis. 2017 Nov 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  90. REID MJA, Goosby E
    Patient-Centered Tuberculosis Programs Are Necessary to End the Epidemic.
    J Infect Dis. 2017;216.
    PubMed     Text format    


  91. NAIDOO P, Theron G, Rangaka MX, Chihota VN, et al
    The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  92. CHURCHYARD G, Kim P, Shah NS, Rustomjee R, et al
    What We Know About Tuberculosis Transmission: An Overview.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  93. MATHEMA B, Andrews JR, Cohen T, Borgdorff MW, et al
    Drivers of Tuberculosis Transmission.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  94. AULD SC, Kasmar AG, Dowdy DW, Mathema B, et al
    Research Roadmap for Tuberculosis Transmission Science: Where Do We Go From Here and How Will We Know When We're There?
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  95. SHAH NS, Kim P, Kana BD, Rustomjee R, et al
    Getting to Zero New Tuberculosis Infections: Insights From the National Institutes of Health/US Centers for Disease Control and Prevention/Bill & Melinda Gates Foundation Workshop on Research Needs for Halting Tuberculosis Transmission.
    J Infect Dis. 2017;216.
    PubMed     Text format    


  96. NEWTON R, Labo N, Wakeham K, Miley W, et al
    Kaposi's sarcoma associated herpesvirus in a rural Ugandan cohort: 1992-2008.
    J Infect Dis. 2017 Nov 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2017
  97. VAN ZOEST RA, Underwood J, De Francesco D, Sabin CA, et al
    Structural brain abnormalities in successfully treated HIV infection: associations with disease and cerebrospinal fluid biomarkers.
    J Infect Dis. 2017 Oct 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  98. SIBERRY GK, Amzel A, Ramos A, Rivadeneira ED, et al
    Impact of Human Immunodeficiency Virus Drug Resistance on Treatment of Human Immunodeficiency Virus Infection in Children in Low- and Middle-Income Countries.
    J Infect Dis. 2017 Oct 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  99. KIRKEGAARD-KLITBO DM, Langkilde A, Mejer N, Andersen O, et al
    Soluble Urokinase Plasminogen Activator Receptor Is a Predictor of Incident Non-AIDS Comorbidity and All-Cause Mortality in Human Immunodeficiency Virus Type 1 Infection.
    J Infect Dis. 2017;216:819-823.
    PubMed     Text format     Abstract available


  100. LI G, Nunoya JI, Cheng L, Reszka-Blanco N, et al
    Regulatory T Cells Contribute to HIV-1 Reservoir Persistence in CD4 T Cells Through cAMP-Dependent Mechanisms in Humanized Mice In Vivo.
    J Infect Dis. 2017 Oct 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  101. BERTAGNOLIO S, Beanland RL, Jordan MR, Doherty M, et al
    The World Health Organization's Response to Emerging Human Immunodeficiency Virus Drug Resistance and a Call for Global Action.
    J Infect Dis. 2017 Oct 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  102. DUARTE HA, Panpradist N, Beck IA, Lutz B, et al
    Current Status of Point-of-Care Testing for Human Immunodeficiency Virus Drug Resistance.
    J Infect Dis. 2017 Oct 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  103. PINTYE J, Baeten JM, Celum C, Mugo N, et al
    Maternal tenofovir disoproxil fumarate use during pregnancy is not associated with adverse perinatal outcomes among HIV-infected East African women: a prospective study.
    J Infect Dis. 2017 Oct 10. doi: 10.1093.
    PubMed     Text format     Abstract available


  104. SILVERMAN RA, Beck IA, Kiptinness C, Levine M, et al
    Prevalence of Pre-antiretroviral Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-infected Individuals Initiating Therapy in Kenya, 2013-2014.
    J Infect Dis. 2017 Oct 10. doi: 10.1093.
    PubMed     Text format     Abstract available


  105. NGOBENI R, Samie A, Moonah S, Watanabe K, et al
    Entamoeba Species in South Africa: Correlations With the Host Microbiome, Parasite Burdens, and First Description of Entamoeba bangladeshi Outside of Asia.
    J Infect Dis. 2017 Oct 8. pii: 4372272. doi: 10.1093.
    PubMed     Text format     Abstract available


  106. ROH ME, Shiboski S, Natureeba P, Kakuru A, et al
    Protective effect of indoor residual spraying of insecticide on preterm birth among pregnant women with HIV in Uganda: A secondary data analysis.
    J Infect Dis. 2017 Oct 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  107. MINIOR T, Douglas M, Edgil D, Srivastava M, et al
    The Critical Role of Supply Chains in Preventing Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Settings.
    J Infect Dis. 2017 Oct 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  108. ZHUKOVA A, Cutino-Moguel T, Gascuel O, Pillay D, et al
    The Role of Phylogenetics as a Tool to Predict the Spread of Resistance.
    J Infect Dis. 2017 Oct 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  109. SINGH D, Dhummakupt A, Siems L, Persaud D, et al
    Alternative Sample Types for HIV-1 Antiretroviral Drug Resistance Testing.
    J Infect Dis. 2017 Oct 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  110. PARASKEVIS D
    Investigation of Human Immunodeficiency Virus Outbreaks Among People Who Inject Drugs: Timely Diagnosis and Molecular Surveillance are Crucial.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    PubMed     Text format    


  111. CHUN HM, Obeng-Aduasare YF, Broyles LN, Ellenberger D, et al
    Expansion of Viral Load Testing and the Potential Impact on Human Immunodeficiency Virus Drug Resistance.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    PubMed     Text format     Abstract available


  112. BUNJUN R, Riou C, Soares AP, Thawer N, et al
    Effect of HIV on the frequency and number of Mycobacterium tuberculosis-specific CD4+ T cells in blood and the airways in latent tuberculosis infection.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    PubMed     Text format     Abstract available


  113. CAMPBELL EM, Jia H, Shankar A, Hanson D, et al
    Detailed Transmission Network Analysis of a Large Opiate-Driven Outbreak of HIV Infection in the United States.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    PubMed     Text format     Abstract available


  114. DONAHUE CARLSON R, Sheth AN, Read TD, Frisch MB, et al
    The Female Genital Tract Microbiome Is Associated With Vaginal Antiretroviral Drug Concentrations in Human Immunodeficiency Virus-Infected Women on Antiretroviral Therapy.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2017
  115. BORRE ED, Hyle EP, Paltiel AD, Neilan AM, et al
    The Clinical and Economic Impact of Attaining National HIV/AIDS Strategy Treatment Targets in the United States.
    J Infect Dis. 2017 Sep 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  116. ADIMORA AA
    Implementing National HIV/AIDS Strategy 2015 Treatment Targets Is Cost-effective and Would Save Lives: What Other Evidence Do We Need?
    J Infect Dis. 2017 Sep 28. doi: 10.1093.
    PubMed     Text format    


  117. PRENDERGAST AJ, Chasekwa B, Rukobo S, Govha M, et al
    Intestinal Damage and Inflammatory Biomarkers in Human Immunodeficiency Virus (HIV)-Exposed and HIV-Infected Zimbabwean Infants.
    J Infect Dis. 2017;216:651-661.
    PubMed     Text format     Abstract available


  118. FOLDI J, Kozhaya L, McCarty B, Mwamzuka M, et al
    HIV-Infected Children Have Elevated Levels of PD-1+ Memory CD4 T Cells With Low Proliferative Capacity and High Inflammatory Cytokine Effector Functions.
    J Infect Dis. 2017;216:641-650.
    PubMed     Text format     Abstract available


  119. ROCKWOOD N, Sirgel F, Streicher E, Warren R, et al
    Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.
    J Infect Dis. 2017;216:632-640.
    PubMed     Text format     Abstract available


  120. KOOIJ KW, Vogt L, Wit FWNM, van der Valk M, et al
    Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls.
    J Infect Dis. 2017;216:622-631.
    PubMed     Text format     Abstract available


  121. MOORE T, Dembry LM, Saag MS
    Sunday in the Park with Infectious Disease: Workforce Mismatch in a Colorful Universe of Possibilities.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  122. GALLANT JE
    Human Immunodeficiency Virus Medicine.
    J Infect Dis. 2017;216.
    PubMed     Text format    


  123. PIROFSKI LA
    Life as an Infectious Diseases Physician Scientist: Science is Humanity's Lifeline.
    J Infect Dis. 2017;216.
    PubMed     Text format    


  124. DEL RIO C
    From Trained Infectious Diseases Clinician to Global Health Leader, Reflections on the Last 30 Years.
    J Infect Dis. 2017;216.
    PubMed     Text format    


  125. NOGUERA-JULIAN M, Edgil D, Harrigan PR, Sandstrom P, et al
    Next-Generation Human Immunodeficiency Virus Sequencing for Patient Management and Drug Resistance Surveillance.
    J Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Text format     Abstract available


  126. GODFREY C, Bobkova M, Boucher C, Ravasi G, et al
    Regional Challenges in the Prevention of Human Immunodeficiency Virus Drug Resistance.
    J Infect Dis. 2017 Sep 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  127. CHIKATA T, Murakoshi H, Koyanagi M, Honda K, et al
    Control of HIV-1 by an HLA-B*52:01-C*12:02 protective haplotype.
    J Infect Dis. 2017 Sep 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  128. MCLAREN PJ, Pulit SL, Gurdasani D, Bartha I, et al
    Evaluating the impact of functional genetic variation on HIV-1 control.
    J Infect Dis. 2017 Sep 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  129. LIU Y, Gaisa MM, Wang X, Swartz TH, et al
    Immune Microenvironments of Anal Cancer Precursors Differ by HIV-serostatus, Affecting Ablation Outcomes.
    J Infect Dis. 2017 Sep 2. doi: 10.1093.
    PubMed     Text format     Abstract available


  130. NING T, Wolfe A, Nie J, Huang W, et al
    Naturally Occurring Single Amino Acid Substitution in the L1 Major Capsid Protein of Human Papillomavirus Type 16: Alteration of Susceptibility to Antibody-Mediated Neutralization.
    J Infect Dis. 2017 Sep 2. doi: 10.1093.
    PubMed     Text format     Abstract available


  131. AKE JA, Schuetz A, Pegu P, Wieczorek L, et al
    Safety and Immunogenicity of PENNVAX(R)-G DNA Prime Administered by Biojector(R) 2000 or CELLECTRA(R) Electroporation Device with Modified Vaccinia Ankara-CMDR Boost.
    J Infect Dis. 2017 Sep 2. doi: 10.1093.
    PubMed     Text format     Abstract available


  132. SMITH B
    Toward Understanding the When and Why of Human Immunodeficiency Virus-Associated Stroke.
    J Infect Dis. 2017;216:509-510.
    PubMed     Text format    


  133. BENJAMIN LA, Allain TJ, Mzinganjira H, Connor MD, et al
    The Role of Human Immunodeficiency Virus-Associated Vasculopathy in the Etiology of Stroke.
    J Infect Dis. 2017;216:545-553.
    PubMed     Text format     Abstract available


  134. MOLLAN KR, Tierney C, Hellwege JN, Eron JJ, et al
    Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants.
    J Infect Dis. 2017;216:554-564.
    PubMed     Text format     Abstract available


    August 2017
  135. WEITZMANN MN, Vikulina T, Roser-Page S, Yamaguchi M, et al
    Homeostatic Expansion of CD4+ T-cells Promotes Cortical and Trabecular Bone Loss while CD8+ T-cells Induce Trabecular Bone Loss Only.
    J Infect Dis. 2017 Aug 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  136. ASMUTH DM, Thompson CG, Chun TW, Ma ZM, et al
    Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal GALT Immune Reconstitution in HIV-infected Patients Initiating Antiretroviral Therapy.
    J Infect Dis. 2017 Aug 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  137. BOEIJEN LL, Montanari NR, de Groen RA, van Oord GW, et al
    Mucosal-associated invariant T (MAIT) cells are more activated in chronic hepatitis B, but not depleted in blood: reversal by antiviral therapy.
    J Infect Dis. 2017 Aug 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  138. DE POKOMANDY A, Kaufman E, de Castro C, Mayrand MH, et al
    The EVVA Cohort Study: Anal and Cervical Type-Specific Human Papillomavirus Prevalence, Persistence, and Cytologic Findings in Women Living With HIV.
    J Infect Dis. 2017;216:447-456.
    PubMed     Text format     Abstract available


  139. CRABTREE KL, Wojcicki JM, Minhas V, Kankasa C, et al
    Food and Drink Sharing in the Household are Associated with HHV-8 Seroconversion in a Cohort of Zambian Children.
    J Infect Dis. 2017 Aug 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  140. CLUTTER DS, Zhou S, Varghese V, Rhee SY, et al
    Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1-Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing.
    J Infect Dis. 2017;216:387-391.
    PubMed     Text format     Abstract available


  141. VAN LAARHOVEN A, Dian S, Ganiem AR, van Crevel R, et al
    Reply to Neeradi et al and Dhawan and Sankhyan.
    J Infect Dis. 2017;216:395-396.
    PubMed     Text format    


    July 2017
  142. HENRICH TJ, Hobbs KS, Hanhauser E, Scully E, et al
    Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy.
    J Infect Dis. 2017;216:254-262.
    PubMed     Text format     Abstract available


  143. MARTIN DH, Manhart LE, Workowski KA
    Mycoplasma genitalium From Basic Science to Public Health: Summary of the Results From a National Institute of Allergy and Infectious Disesases Technical Consultation and Consensus Recommendations for Future Research Priorities.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  144. HORNER PJ, Martin DH
    Mycoplasma genitalium Infection in Men.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


    June 2017
  145. DELAUGERRE C, Antoni G, Mahjoub N, Pialoux G, et al
    Assessment of HIV Screening Tests for Pre-Exposure Prophylaxis Programs.
    J Infect Dis. 2017 Jun 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  146. SCHOEMAN JC, Moutloatse GP, Harms AC, Vreeken RJ, et al
    Fetal metabolic stress disrupts immune homeostasis and induces pro-inflammatory responses in HIV-1 and cART-exposed infants.
    J Infect Dis. 2017 Jun 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  147. GODFREY C, Thigpen MC, Crawford KW, Jean-Phillippe P, et al
    Global HIV Antiretroviral Drug Resistance: A Perspective and Report of a National Institute of Allergy and Infectious Diseases Consultation.
    J Infect Dis. 2017 Jun 17. doi: 10.1093.
    PubMed     Text format    


  148. KOPP JB
    Chronic Kidney Disease in the Aging Human Immunodeficiency Virus-Infected Population.
    J Infect Dis. 2017 Jun 13. doi: 10.1093.
    PubMed     Text format    


    May 2017
  149. HIRAKAWA H, Gatanaga H, Ochi H, Fukuda T, et al
    Antiretroviral therapy containing HIV protease inhibitors enhances fracture risk by impairing osteoblast differentiation and bone quality.
    J Infect Dis. 2017 May 19. doi: 10.1093.
    PubMed     Text format     Abstract available


  150. STEINAU M, Gorbach P, Gratzer B, Braxton J, et al
    Concordance between Anal and Oral Human Papillomavirus (HPV) Infections Among Young Men Who Have Sex with Men.
    J Infect Dis. 2017 May 15. doi: 10.1093.
    PubMed     Text format     Abstract available


  151. KEATING SM, Pilcher CD, Jain V, Lebedeva M, et al
    HIV Antibodies Detect HIV Persistence and Low Level Viral Replication.
    J Infect Dis. 2017 May 11. doi: 10.1093.
    PubMed     Text format     Abstract available


  152. LUO Z, Li Z, Martin L, Wan Z, et al
    Pathological role of anti-CD4 antibodies in HIV-infected immunologic non-responders under viral suppressive antiretroviral therapy.
    J Infect Dis. 2017 May 11. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2017
  153. GAY CL, Bosch RJ, Ritz J, Hataye JM, et al
    Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy.
    J Infect Dis. 2017 Apr 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  154. THUONG NTT, Heemskerk D, Tram TTB, Thao LTP, et al
    Leukotriene A4 Hydrolase Genotype and HIV Infection Influence Intracerebral Inflammation and Survival From Tuberculous Meningitis.
    J Infect Dis. 2017 Apr 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  155. VAN LAARHOVEN A, Dian S, Ruesen C, Hayati E, et al
    Clinical Parameters, Routine Inflammatory Markers, and LTA4H Genotype as Predictors of Mortality Among 608 Patients With Tuberculous Meningitis in Indonesia.
    J Infect Dis. 2017 Apr 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  156. CHOI JY, Pond SLK, Anderson CM, Richman DD, et al
    Molecular Features of the V1-V4 Coding Region of Sexually Transmitted HIV-1.
    J Infect Dis. 2017 Apr 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  157. SYPSA V, Psichogiou M, Paraskevis D, Nikolopoulos G, et al
    Rapid Decline in HIV Incidence Among Persons Who Inject Drugs During a Fast-Track Combination Prevention Program After an HIV Outbreak in Athens.
    J Infect Dis. 2017 Apr 12. doi: 10.1093.
    PubMed     Text format     Abstract available


  158. CHAN PA, Flanigan TP
    Effective HIV Prevention Interventions and the Need for Rapid Mobilization to Address HIV Outbreaks Among At-Risk Populations.
    J Infect Dis. 2017 Apr 12. doi: 10.1093.
    PubMed     Text format    


  159. HERRERA BB, Chang CA, Hamel DJ, Mboup S, et al
    Continued transmission of Zika virus in humans in West Africa, 1992-2016.
    J Infect Dis. 2017 Apr 8. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2017
  160. VERMUND SH
    The Continuum of HIV Care in the Urban United States: Black Men Who Have Sex With Men (MSM) Are Less Likely Than White MSM to Receive Antiretroviral Therapy.
    J Infect Dis. 2017 Mar 29. doi: 10.1093.
    PubMed     Text format    


  161. RAHIMY E, Li FY, Hagberg L, Fuchs D, et al
    Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.
    J Infect Dis. 2017 Mar 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  162. HOOTS BE, Finlayson TJ, Wejnert C, Paz-Bailey G, et al
    Updated Data on Linkage to Human Immunodeficiency Virus Care and Antiretroviral Treatment Among Men Who Have Sex With Men-20 Cities, United States.
    J Infect Dis. 2017 Mar 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  163. DING Y, Lin H, Liu X, Wong FY, et al
    Higher Prevalence of Frailty Among a Sample of HIV-Infected Middle-aged and Older Chinese Adults Is Associated With Neurocognitive Impairment and Depressive Symptoms.
    J Infect Dis. 2017 Mar 16. doi: 10.1093.
    PubMed     Text format     Abstract available


  164. ERLANDSON KM, Wu K, Koletar SL, Kalayjian RC, et al
    Association Between Frailty and Components of the Frailty Phenotype With Modifiable Risk Factors and Antiretroviral Therapy.
    J Infect Dis. 2017;215:933-937.
    PubMed     Text format     Abstract available


  165. KHOURY G, Fromentin R, Solomon A, Hartogensis W, et al
    Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy.
    J Infect Dis. 2017;215:911-919.
    PubMed     Text format     Abstract available


  166. UPRETY P, Lindsey JC, Levin MJ, Rainwater-Lovett K, et al
    Inflammation and Immune Activation in Antiretroviral-Treated Human Immunodeficiency Virus Type 1-Infected African Infants and Rotavirus Vaccine Responses.
    J Infect Dis. 2017;215:928-932.
    PubMed     Text format     Abstract available


  167. MARGOT NA, Wong P, Kulkarni R, White K, et al
    Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment-Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide.
    J Infect Dis. 2017;215:920-927.
    PubMed     Text format     Abstract available


  168. CELUM C, Hong T, Cent A, Donnell D, et al
    Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study.
    J Infect Dis. 2017;215:907-910.
    PubMed     Text format     Abstract available


  169. BORITZ EA, Douek DC
    Perspectives on Human Immunodeficiency Virus (HIV) Cure: HIV Persistence in Tissue.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  170. RILEY JL, Montaner LJ
    Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  171. HENRICH TJ, Deeks SG, Pillai SK
    Measuring the Size of the Latent Human Immunodeficiency Virus Reservoir: The Present and Future of Evaluating Eradication Strategies.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  172. NIXON CC, Mavigner M, Silvestri G, Garcia JV, et al
    In Vivo Models of Human Immunodeficiency Virus Persistence and Cure Strategies.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  173. MULLINS JI, Frenkel LM
    Clonal Expansion of Human Immunodeficiency Virus-Infected Cells and Human Immunodeficiency Virus Persistence During Antiretroviral Therapy.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  174. MARGOLIS DM
    Towards an HIV Cure: a View of a Developing Field.
    J Infect Dis. 2017;215.
    PubMed     Text format    


  175. MARGOLIS DM, Archin NM
    Proviral Latency, Persistent Human Immunodeficiency Virus Infection, and the Development of Latency Reversing Agents.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  176. FERRARI G, Pollara J, Tomaras GD, Haynes BF, et al
    Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  177. WYLES D, Saag M, Viani RM, Lalezari J, et al
    TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on Darunavir.
    J Infect Dis. 2017 Mar 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  178. LEE S, Byakwaga H, Boum Y, Burdo TH, et al
    Immunologic Pathways that Predict Mortality in HIV-Infected Ugandans Initiating ART.
    J Infect Dis. 2017 Mar 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2017
  179. TER KUILE FO, Taylor SM
    Gilding the lily?: Enhancing antenatal malaria prevention in HIV-infected women.
    J Infect Dis. 2017 Feb 28. doi: 10.1093.
    PubMed     Text format    


  180. NATUREEBA P, Kakuru A, Muhindo M, Littmann E, et al
    Intermittent Preventive Treatment with Dihydroartemisinin-piperaquine for the Prevention of Malaria among HIV-infected Pregnant Women.
    J Infect Dis. 2017 Feb 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  181. PHILLIPS AN, Stover J, Cambiano V, Nakagawa F, et al
    Impact of HIV drug resistance on HIV/AIDS associated mortality, new infections and antiretroviral therapy program costs in sub-Saharan Africa.
    J Infect Dis. 2017 Feb 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  182. LEVIS W
    Clofazimine mechanisms of action in Mycobacteria, HIV, and Cancer.
    J Infect Dis. 2017 Feb 12. doi: 10.1093.
    PubMed     Text format    


  183. HANNA DB, Lin J, Post WS, Hodis HN, et al
    Association of macrophage inflammation biomarkers with progression of subclinical carotid artery atherosclerosis in HIV-infected women and men.
    J Infect Dis. 2017 Feb 12. doi: 10.1093.
    PubMed     Text format    


  184. JANES HE, Cohen KW, Frahm N, De Rosa SC, et al
    Higher T cell responses induced by DNA/rAd5 HIV-1 preventive vaccine are associated with lower HIV-1 infection risk in an efficacy trial.
    J Infect Dis. 2017 Feb 12. doi: 10.1093.
    PubMed     Text format    


  185. FEINSTEIN MJ, Lloyd-Jones DM
    Macrophage inflammation and cardiovascular disease in HIV: Mechanistic Insights and Future Directions.
    J Infect Dis. 2017 Feb 12. doi: 10.1093.
    PubMed     Text format    


  186. DZANIBE S, Adrian PV, Mlacha SZ, Dangor Z, et al
    Reduced Transplacental Transfer of Group B Streptococcus Surface Protein Antibodies in HIV-infected Mother-Newborn Dyads.
    J Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed     Text format    


  187. KHOURY G, Fromentin R, Solomon A, Hartogensis W, et al
    HIV persistence and T-cell activation in blood, rectal and lymph node tissue in HIV-infected individuals receiving suppressive ART.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format    


  188. GARGANO JW, Unger ER, Liu G, Steinau M, et al
    Prevalence of Genital Human Papillomavirus in Males, United States, 2013-2014.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format    


  189. UPRETY P, Lindsey JC, Levin MJ, Rainwater-Lovett K, et al
    Inflammation and Immune Activation in Antiretroviral-Treated HIV-1-Infected African Infants and Rotavirus Vaccine Responses.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format    


    January 2017
  190. MARGOT NA, Wong P, Kulkarni R, White K, et al
    Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse Transcriptase and Protease in Antiretroviral Treatment-Naive Patients do not Affect Response to Tenofovir Disoproxil Fumarate- or Tenofovir Alafenamide-Containing Regimens.
    J Infect Dis. 2017 Jan 30. doi: 10.1093.
    PubMed     Text format     Abstract available


  191. CELUM C, Hong T, Cent A, Donnell D, et al
    HSV-2 acquisition among HIV-1 infected adults treated with tenofovir as part of combination antiretroviral therapy: Results from the ACTG A5175 PEARLS study.
    J Infect Dis. 2017 Jan 30. doi: 10.1093.
    PubMed     Text format     Abstract available


  192. LOFGREN S, Hullsiek KH, Morawski BM, Nabeta HW, et al
    Differences in Immunologic Factors Among Patients Presenting with Altered Mental Status During Cryptococcal Meningitis.
    J Infect Dis. 2017 Jan 30. doi: 10.1093.
    PubMed     Text format     Abstract available


  193. LIN WW, Nelson A, Ryon JJ, Moss WJ, et al
    Plasma cytokines and chemokines in Zambian children with measles: innate responses and association with HIV-1 co-infection and in-hospital mortality.
    J Infect Dis. 2017 Jan 24. pii: jix012. doi: 10.1093.
    PubMed     Text format     Abstract available


  194. ZANNI MV, Toribio M, Wilks MQ, Lu MT, et al
    Application of a Novel CD206+ Macrophage-Specific Arterial Imaging Strategy in HIV.
    J Infect Dis. 2017 Jan 16. doi: 10.1093.
    PubMed     Text format    


  195. JANSSEN S, Schutz C, Ward AM, Huson MA, et al
    Hemostatic Changes Associated With Increased Mortality Rates in Hospitalized Patients With HIV-Associated Tuberculosis: A Prospective Cohort Study.
    J Infect Dis. 2017;215:247-258.
    PubMed     Text format     Abstract available


  196. HOBBS CV, Anderson C, Neal J, Sahu T, et al
    Trimethoprim-Sulfamethoxazole Prophylaxis During Live Malaria Sporozoite Immunization Induces Long-Lived, Homologous, and Heterologous Protective Immunity Against Sporozoite Challenge.
    J Infect Dis. 2017;215:122-130.
    PubMed     Text format     Abstract available


  197. NYOMBAYIRE J, Anzala O, Gazzard B, Karita E, et al
    First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.
    J Infect Dis. 2017;215:95-104.
    PubMed     Text format     Abstract available


  198. OTTICHILO RK, Polyak CS, Guyah B, Singa B, et al
    Malaria Parasitemia and Parasite Density in Antiretroviral-Treated HIV-Infected Adults Following Discontinuation of Cotrimoxazole Prophylaxis.
    J Infect Dis. 2017;215:88-94.
    PubMed     Text format     Abstract available


    December 2016
  199. CHENG A, Chang SY, Sun HY, Tsai MS, et al
    Long-term durability of responses to 2 or 3 doses of hepatitis A vaccination in HIV-positive adults on antiretroviral therapy.
    J Infect Dis. 2016 Dec 23. pii: jiw605. doi: 10.1093.
    PubMed     Text format     Abstract available


  200. GRABOWSKI MK, Gravitt PE, Gray RH, Serwadda D, et al
    Trends and determinants of human papillomavirus concordance among HIV-positive and HIV-negative heterosexual couples in Rakai, Uganda.
    J Infect Dis. 2016 Dec 23. pii: jiw631. doi: 10.1093.
    PubMed     Text format     Abstract available


  201. EVANS C, Chasekwa B, Rukobo S, Govha M, et al
    CMV acquisition and inflammation in HIV-exposed uninfected Zimbabwean infants.
    J Infect Dis. 2016 Dec 23. pii: jiw630. doi: 10.1093.
    PubMed     Text format     Abstract available


  202. BIRSE KD, Romas LM, Guthrie BL, Nilsson P, et al
    Genital injury signatures and microbiome alterations associated with depot medroxyprogesterone acetate usage and intravaginal drying practices.
    J Infect Dis. 2016 Dec 23. pii: jiw590. doi: 10.1093.
    PubMed     Text format     Abstract available


  203. BALKUS JE, Srinivasan S, Anzala O, Kimani J, et al
    Impact of periodic presumptive treatment for bacterial vaginosis on the vaginal microbiome among women participating in the Preventing Vaginal Infections trial.
    J Infect Dis. 2016 Dec 22. pii: jiw622. doi: 10.1093.
    PubMed     Text format     Abstract available


  204. MESQUITA PM, Preston-Hurlburt P, Keller MJ, Vudattu N, et al
    Role of IL-32 in HIV Reactivation and its Link to HIV-HSV Coinfection.
    J Infect Dis. 2016 Dec 22. pii: jiw612. doi: 10.1093.
    PubMed     Text format     Abstract available


  205. BIALAS KM, Westreich D, Cisneros de la Rosa E, Nelson CS, et al
    Maternal Antibody Responses and Nonprimary Congenital Cytomegalovirus Infection of HIV-1-Exposed Infants.
    J Infect Dis. 2016;214:1916-1923.
    PubMed     Text format     Abstract available


  206. STEEGEN K, Bronze M, Papathanasopoulos MA, van Zyl G, et al
    Prevalence of Antiretroviral Drug Resistance in Patients Who Are Not Responding to Protease Inhibitor-Based Treatment: Results From the First National Survey in South Africa.
    J Infect Dis. 2016;214:1826-1830.
    PubMed     Text format     Abstract available


  207. MARAIS S, Lai RP, Wilkinson KA, Meintjes G, et al
    Inflammasome activation underlies central nervous system deterioration in HIV-associated tuberculosis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  208. MCFARLAND EJ, Powell TM, Onyango-Makumbi C, Zhang W, et al
    Ontogeny of CD4+ T Lymphocytes with Phenotypic Susceptibility to HIV-1 during Exclusive and Non-Exclusive Breastfeeding in HIV-1-exposed Ugandan Infants.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  209. DZANIBE S, Adrian PV, Kimaro Mlacha SZ, Dangor Z, et al
    Reduced trans-placental transfer of group B Streptococcus surface protein antibodies in HIV-infected mother-newborn dyads.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  210. TSO FY, Sawyer A, Kwon EH, Mudenda V, et al
    Kaposi's sarcoma-associated herpesvirus infection of neurons in HIV positive patients.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  211. BRAUNSTEIN SL, Robertson MM, Myers J, Abraham B, et al
    Increase in CD4+ T-Cell Count at the Time of HIV Diagnosis and Antiretroviral Treatment Initiation Among Persons With HIV in New York City.
    J Infect Dis. 2016;214:1682-1686.
    PubMed     Text format     Abstract available


    November 2016
  212. ALTHOFF KN
    The Shifting Paradigm of Care for Adults Living With HIV: Smoking Cessation for Longer Life.
    J Infect Dis. 2016.
    PubMed     Text format    


  213. REDDY KP, Parker RA, Losina E, Baggett TP, et al
    Impact of Cigarette Smoking and Smoking Cessation on Life Expectancy Among People With HIV: A US-Based Modeling Study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  214. GULICK RM, Wilkin TJ, Chen YQ, Landovitz RJ, et al
    PHASE 2 STUDY OF THE SAFETY AND TOLERABILITY OF MARAVIROC-CONTAINING REGIMENS TO PREVENT HIV INFECTION IN MEN WHO HAVE SEX WITH MEN (MSM) (HPTN 069/ACTG A5305).
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  215. GUNTHARD HF, Scherrer AU
    HIV-1 Subtype C, Tenofovir, and the Relationship With Treatment Failure and Drug Resistance.
    J Infect Dis. 2016;214:1289-1291.
    PubMed     Text format    


    October 2016
  216. ERLANDSON KM, Ng D, Jacobson LP, Margolick JB, et al
    Inflammation, Immune Activation, Immunosenescence, and Hormonal Biomarkers in the Frailty-Related Phenotype of Men with or at Risk for HIV.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  217. IMP BM, Rubin LH, Tien PC, Plankey MW, et al
    Monocyte Activation is Associated with Worse Cognitive Performance in Virologically Suppressed HIV-Infected Women.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  218. ANDERSON AM, Munoz-Moreno JA, McClernon D, Ellis RJ, et al
    Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  219. MUDD JC, Panigrahi S, Kyi B, Moon SH, et al
    Inflammatory function of CX3CR1+ CD8 T cells in treated HIV infection is modulated by platelet interactions.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  220. ECKARD AR, Meissner EG, Singh I, McComsey GA, et al
    Cardiovascular Disease, Statins, and HIV.
    J Infect Dis. 2016;214 Suppl 2:S83-92.
    PubMed     Text format     Abstract available


  221. KOETHE JR, Heimburger DC, PrayGod G, Filteau S, et al
    From Wasting to Obesity: The Contribution of Nutritional Status to Immune Activation in HIV Infection.
    J Infect Dis. 2016;214 Suppl 2:S75-82.
    PubMed     Text format     Abstract available


  222. GIANELLA S, Letendre S
    Cytomegalovirus and HIV: A Dangerous Pas de Deux.
    J Infect Dis. 2016;214 Suppl 2:S67-74.
    PubMed     Text format     Abstract available


  223. MUDD JC, Brenchley JM
    Gut Mucosal Barrier Dysfunction, Microbial Dysbiosis, and Their Role in HIV-1 Disease Progression.
    J Infect Dis. 2016;214 Suppl 2:S58-66.
    PubMed     Text format     Abstract available


  224. FREEMAN ML, Shive CL, Nguyen TP, Younes SA, et al
    Cytokines and T-Cell Homeostasis in HIV Infection.
    J Infect Dis. 2016;214 Suppl 2:S51-7.
    PubMed     Text format     Abstract available


  225. HUNT PW, Lee SA, Siedner MJ
    Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection.
    J Infect Dis. 2016;214 Suppl 2:S44-50.
    PubMed     Text format     Abstract available


  226. SIEG SF
    Persistent Inflammation in Treated HIV Disease.
    J Infect Dis. 2016;214 Suppl 2:S43.
    PubMed     Text format    


    September 2016
  227. KOOIJ KW, Wit FW, Booiman T, van der Valk M, et al
    Cigarette smoking and inflammation, monocyte activation and coagulation in HIV-infected individuals on antiretroviral therapy compared to uninfected individuals.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  228. EDEN A, Nilsson S, Hagberg L, Fuchs D, et al
    Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: a Longitudinal Study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  229. WANG L, Wiener J, Bulterys M, Wei X, et al
    Hepatitis B Viral Load Response to two Antiviral Regimens (Tenofovir/Lamivudine vs Lamivudine) in HIV and HBV Co-Infected Pregnant Women in Guangxi, China: the Tenofovir in Pregnancy (TiP) Study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  230. BUCHACZ K, Lau B, Jing Y, Bosch R, et al
    Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010.
    J Infect Dis. 2016;214:862-72.
    PubMed     Text format     Abstract available


  231. FURRER H
    Opportunistic Diseases During HIV Infection-Things Aren't What They Used to Be, or Are They?
    J Infect Dis. 2016;214:830-1.
    PubMed     Text format    


  232. PETERSON I, Bar-Zeev N, Kennedy N, Ho A, et al
    Respiratory virus-associated severe acute respiratory illness (SARI) and viral clustering in Malawian children in a setting with a high prevalence of HIV, malaria and malnutrition.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  233. POPESCU I, Drummond MB, Gama L, Lambert A, et al
    HIV Suppression Restores Lung Mucosal CD4+ T-Cell Viral Immunity and Resolves CD8+ Alveolitis in Patients at Risk for HIV-associated COPD.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    August 2016
  234. IMAZ A, Martinez-Picado J, Niubo J, Kashuba AD, et al
    HIV-1-RNA Decay and Dolutegravir Concentrations in Semen of Patients Initiating a First Antiretroviral Regimen.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  235. COOMBS RW, Krieger JN
    Semen Remains the Way Forward to understand HIV-1 Transmission.
    J Infect Dis. 2016.
    PubMed     Text format    


  236. RODRIGO C, Eltahla AA, Bull RA, Grebely J, et al
    Historical trends in the hepatitis C virus epidemics in North America and Australia.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  237. GUTIERREZ J, Menshawy K, Goldman J, Dwork AJ, et al
    Metalloproteinases and brain arterial remodeling with and without HIV.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  238. SRINIVASA S, Burdo TH, Williams KC, Mitten EK, et al
    Effects of Sodium Restriction on Activation of the Renin-Angiotensin-Aldosterone System and Immune Indices in HIV.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  239. KOSTADINOVA L, Shive C, Judge C, Zebrowski E, et al
    During HCV and HCV-HIV infection elevated plasma Autotaxin is associated with LPA and markers of immune activation that normalize during IFN-free HCV therapy.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  240. MOFENSON LM
    Early Infant HIV Diagnosis: How Early is Early Enough?
    J Infect Dis. 2016.
    PubMed     Text format    


  241. FRANCKE JA, Penazzato M, Hou T, Abrams EJ, et al
    Clinical impact and cost-effectiveness of early infant HIV diagnosis in South Africa: Test timing and frequency.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  242. WALTER ND, de Jong BC, Garcia BJ, Dolganov GM, et al
    Adaptation of M. tuberculosis to impaired host immunity in HIV-infected patients.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  243. REIMERS LL, Mehta SD, Massad LS, Burk RD, et al
    The Cervicovaginal Microbiota and Its Associations with Human Papillomavirus (HPV) Detection in HIV-Infected and HIV-Uninfected Women.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  244. MARKOWITZ M, Deren S, Cleland C, La Mar M, et al
    Chronic hepatitis C infection and the pro-inflammatory effects of injection drug use.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  245. KILIANSKI A, Nuzzo JB, Modjarrad K
    Reply to Lipsitch.
    J Infect Dis. 2016.
    PubMed     Text format    


  246. GONZALEZ OA, Sagar M
    Antibodies and acidic environment do not enhance HIV-1 transcytosis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  247. RYOM L, Lundgren JD, Ross M, Kirk O, et al
    Renal Impairment and Cardiovascular Disease in HIV-positive Individuals; The D:A:D Study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  248. FIERER DS
    The Order of Addition of Immunocompromise: The Effects of HIV Infection on Fibrosis Progression of Hepatitis C-infected Patients.
    J Infect Dis. 2016.
    PubMed     Text format    


    July 2016
  249. MASSUD I, Mitchell J, Babusis D, Deyounks F, et al
    Chemoprophylaxis with oral emtricitabine and tenofovir alafenamide combination protects macaques from rectal SHIV infection.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  250. WALL KM, Kilembe W, Vwalika B, Ravindhran P, et al
    Hormonal contraceptive use among HIV-positive women and HIV transmission risk to male partners, Zambia, 1994-2012.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  251. DIEDRICH CR, O'Hern J, Gutierrez MG, Allie N, et al
    Relationship between HIV-1 co-infection, IL-10, and M. tuberculosis in human lymph node granulomas.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  252. CANADAY DH, Toossi Z
    Granulomatous responses in HIV/TB co-infection.
    J Infect Dis. 2016.
    PubMed     Text format    


  253. BAETEN JM
    Making an Impact With Preexposure Prophylaxis for Prevention of HIV Infection.
    J Infect Dis. 2016.
    PubMed     Text format    


  254. JENNESS SM, Goodreau SM, Rosenberg E, Beylerian EN, et al
    Impact of the Centers for Disease Control's HIV Preexposure Prophylaxis Guidelines for Men Who Have Sex With Men in the United States.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  255. BOENDER TS, Hamers RL, Ondoa P, Wellington M, et al
    Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    June 2016
  256. DERUAZ M, Moldt B, Le KM, Power KA, et al
    Protection of Humanized Mice From Repeated Intravaginal HIV Challenge by Passive Immunization: A Model for Studying the Efficacy of Neutralizing Antibodies In Vivo.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  257. HUNT PW
    sCD163 and Clinical Outcomes in Treated HIV: Insights into Mechanisms.
    J Infect Dis. 2016.
    PubMed     Text format    


  258. KELESIDIS T, Moser C, Stein JH, Brown TT, et al
    Changes in markers of T cell senescence and exhaustion with Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  259. KNUDSEN TB, Ertner G, Petersen J, Moller HJ, et al
    Plasma CD163 independently predicts all-cause mortality from HIV-1 infection.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  260. GRANT PM, Kitch D, McComsey GA, Collier AC, et al
    Long-term Bone Mineral Density Changes in Antiretroviral-Treated HIV-Infected Individuals.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  261. MEITES E, Gorbach PM, Gratzer B, Panicker G, et al
    Monitoring for HPV Vaccine Impact among Gay, Bisexual and other Men who have Sex with Men - United States, 2012-2014.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  262. CHEN YI MEI SL, Burchell J, Skinner N, Millen R, et al
    Toll-like receptor expression and signalling in peripheral blood mononuclear cells correlate with clinical outcomes in acute hepatitis C infection.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    May 2016
  263. LAPRISE JF, Markowitz LE, Chesson HW, Drolet M, et al
    COMPARING 2- AND 3-DOSE 9-VALENT HPV VACCINE SCHEDULES IN THE U.S.: A COST-EFFECTIVENESS ANALYSIS.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  264. WHITE E, Smit E, Churchill D, Collins S, et al
    No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  265. SHILAIH M, Marzel A, Scherrer AU, Braun DL, et al
    Dually Active HIV/HBV Antiretrovirals Protect Against Incident Hepatitis B Infections: Potential for Prophylaxis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  266. PRENDERGAST AJ, Szubert AJ, Berejena C, Pimundu G, et al
    Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: